Statin Market (Updated Version Available)

The report offers detailed coverage of Statin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Statin by geography. The report splits the market size, by volume and value, on the basis of application type and geography.


Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. 
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases and diabetes which in turn is expected to drive the demand for statins worldwide.  In North America, over 70% American adults are suffering from LDL cholesterol. As such, demand for effective treatment of LDL cholesterol has led to increased demand of statins globally. Furthermore, increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol related healthcare campaign is expected to boost overall demand for stains worldwide.
Though the market is poised to grow at a significant rate, increasing preference for alternative medicines in emerging regions is proving a major challenge for overall growth of the stains market. Degrading socioeconomic conditions is another key restraint for this market.


The report forecast global Statin market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.

First, this report covers the present status and the future prospects of the global Statin market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma
By the product type, the market is primarily split into
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
By the end users/application, this report covers the following segments
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others


At the same time, we classify Statin according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Statin market for the forecast period 2020 - 2025?
• What are the driving forces in the Statin market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Statin industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?